Performance of LEGN Legend Biotech Corp | -35% in 12m

Compare LEGN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Legend Biotech Corp with its related Sector/Index XBI

Compare Legend Biotech Corp with its related Sector/Index XBI

Performance Duell LEGN vs XBI

TimeFrame LEGN XBI
1 Day -3.10% -1.05%
1 Week -7.82% -0.08%
1 Month -23.6% -9.83%
3 Months -20.6% -3.21%
6 Months -33.8% 27.79%
12 Months -35.0% 3.13%
YTD -26.0% -6.22%
Rel. Perf. 1m -1.38
Rel. Perf. 3m -3.28
Rel. Perf. 6m -6.27
Rel. Perf. 12m -4.68

Is Legend Biotech Corp a good stock to buy?

No, based on ValueRay Fundamental Analyses, Legend Biotech Corp (NASDAQ:LEGN) is currently (May 2024) a stock to sell. It has a ValueRay Fundamental Rating of -54.14 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LEGN as of May 2024 is 46.22. This means that LEGN is currently overvalued and has a potential downside of 5.67% (Sold with Premium).

Is LEGN a buy, sell or hold?

  • Strong Buy: 9
  • Buy: 9
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
Legend Biotech Corp has received a consensus analysts rating of 4.29. Therefor, it is recommend to buy LEGN.
Values above 0%: LEGN is performing better - Values below 0%: LEGN is underperforming

Compare LEGN with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -7.09% -19.70% -54.69% -57.51%
US NASDAQ 100 QQQ -7.71% -18.98% -55.28% -67.61%
US Dow Jones Industrial 30 DIA -6.03% -19.26% -49.29% -48.20%
German DAX 40 DBXD -6.61% -21.56% -54.83% -48.41%
UK FTSE 100 ISFU -9.78% -26.11% -50.70% -44.32%
Shanghai Shenzhen CSI 300 CSI 300 -10.49% -24.01% -35.25% -22.18%
Hongkong Hang Seng HSI -13.00% -26.05% -31.82% -15.25%
Japan Nikkei 225 EXX7 -7.45% -17.54% -50.74% -53.91%
India NIFTY 50 INDA -8.47% -25.23% -54.87% -62.50%
Brasil Bovespa EWZ -7.40% -21.05% -41.73% -52.37%

LEGN Legend Biotech Corp vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -4.19% -18.18% -54.72% -66.17%
Consumer Discretionary XLY -9.61% -19.78% -49.72% -55.84%
Consumer Staples XLP -8.01% -23.23% -46.73% -35.22%
Energy XLE -5.12% -21.89% -45.53% -49.90%
Financial XLF -5.95% -19.91% -59.61% -59.13%
Health Care XLV -7.13% -19.37% -47.39% -41.22%
Industrial XLI -6.56% -20.78% -58.41% -57.85%
Materials XLB -8.22% -19.20% -51.56% -47.30%
Real Estate XLRE -6.97% -16.74% -45.05% -35.17%
Technology XLK -7.38% -17.54% -53.93% -66.06%
Utilities XLU -8.42% -25.84% -47.60% -34.86%
Aerospace & Defense XAR -8.46% -21.36% -52.42% -54.14%
Biotech XBI -7.74% -13.73% -61.59% -38.08%
Homebuilder XHB -6.85% -16.72% -77.58% -81.50%
Retail XRT -6.11% -15.06% -56.93% -54.18%

LEGN Legend Biotech Corp vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -5.82% -21.94% -38.28% -52.73%
Natural Gas UNG -1.34% -17.39% 18.07% 11.65%
Gold GLD -6.35% -25.51% -48.89% -50.12%
Silver SLV -4.06% -28.77% -48.43% -40.02%
Copper CPER -10.13% -35.06% -58.51% -52.32%

Returns of LEGN vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -6.91% -18.88% -41.43% -23.43%
iShares High Yield Corp. Bond HYG -7.27% -22.61% -42.19% -42.91%
Does Legend Biotech Corp outperform its market, is LEGN a Sector Leader?
No, over the last 12 months Legend Biotech Corp (LEGN) made -34.95%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.13%.
Over the last 3 months LEGN made -20.56%, while XBI made -3.21%.
Period LEGN XBI S&P 500
1 Month -23.56% -9.83% -3.86%
3 Months -20.56% -3.21% 4.28%
12 Months -34.95% 3.13% 22.56%